PouchDaily topic
Nicotine-pouch reporting, research and analysis connected to FDA.
science
Scientists reviewed 73 new nicotine pouch studies. Here's the full picture.An updated scoping review in Nicotine & Tobacco Research covers 73 new pouch studies: US youth use hit 1.8%, adult sales tripled since 2021, high-strength pouches deliver more nicotine than cigarettes — and pouches remain considerably less toxic than cigarettes, with long-term effects still unknown.
regulation
Congress's audit wing just put a number on FDA's pouch backlog: 132,000 products, 3.5 years and countingA new GAO audit found 131,915 tobacco product applications still waiting for a final FDA decision at the end of 2025 — pending applications had waited an average of 1,266 days against a 180-day statutory goal. It also confirms FDA's nicotine pouch pilot is now the template for how other categories get reviewed.
regulation
FDA wants to replace the PMTA rule that decides which pouches are legal — and open up in the processThe FDA says it plans new rulemaking to replace the PMTA framework, citing an illicit market, a federal lawsuit and a flood of new products — while publishing a transparency roadmap.
trend
FDA Opens Advisory Committee Recruitment — and Nicotine Pouches Could Be on the AgendaThe FDA is recruiting new scientific and consumer members for its advisory committees, which provide independent input on tobacco products including nicotine pouches.
regulation
What FDA's modified-risk order for ZYN actually allows — and what it doesn'tIn June 2026, FDA let 20 ZYN pouches carry a reduced-risk claim versus cigarettes — the first ever for nicotine pouches. Here's what the order covers, what it requires, and why it's a precedent.
market
Schumer Pushes FDA to Use Enforcement Powers Against Illegal Vapes—Pouch Crackdown Could FollowSen. Chuck Schumer is calling on the FDA to remove unlawful vaping products from the market. The letter to acting Commissioner Kyle Diamantas could signal broader enforcement against unauthorized nicotine products—including pouches.
market
FDA rolls out new registration form that lets pouch makers update listings without refiling everythingThe FDA's redesigned tobacco product registration form now allows companies to update specific details—like new SKUs or strength changes—without resubmitting unchanged information.
market
FDA to Overhaul PMTA Process After Years of Industry BacklashThe Trump administration is set to revisit the FDA's 2021 premarket tobacco application requirements, a move that could reshape how nicotine pouches and other products get to market after years of delays and criticism.
market
ZYN Dry Pouches Now Come in Four Strengths — and the Can Is About to Get BiggerPMI U.S. is adding 1.5 mg and 8 mg options to the flagship ZYN dry lineup and moving 3 mg and 6 mg cans to 20 pouches in Q4 — the widest strength range the brand has shipped in the US.
market
FDA Names Brian Koplow Permanent Director of Tobacco CenterThe FDA has appointed Brian Koplow as the permanent director of the Center for Tobacco Products, ending a period of acting leadership. Koplow has been at the agency since 2011 and was most recently serving as CTP's acting director.
trend
GTNF 2026: Nicotine Pouch Innovation Now Tied to Regulatory Approval SpeedAt this year's Global Tobacco & Nicotine Forum, the message was blunt: new pouch tech means nothing if regulators won't clear it for market.
market
FDA Authorizes New ZYN Pouches and JUUL2 for U.S. MarketThe FDA has granted marketing authorization to new ZYN nicotine pouch products and the JUUL2 vaping system, allowing legal sale in the U.S. market.
market
U.S. Bureau of Prisons under fire for exclusive deal selling unauthorized nicotine pouches to inmatesThe federal Bureau of Prisons is facing scrutiny over an exclusive contract with a startup selling non-FDA-authorized nicotine pouches to prisoners.
market
Altria Sues FDA Over Missed Review Deadlines for Tobacco ProductsAltria is taking the FDA to court over blown statutory deadlines for product reviews, claiming the agency's recent fixes haven't solved the backlog.
regulation
FDA greenlights 11 ZYN Ultra pouches — including its first 11mgOn 21 August 2026 the FDA issued Marketing Granted Orders for 11 ZYN Ultra nicotine pouches from Swedish Match USA — ten 9mg flavours and a new 11mg Smooth. The authorizations push the total of FDA-authorized nicotine pouch products to 43, with 23 cleared through the agency’s nicotine pouch pilot program. The American Lung Association attacked the move, citing youth appeal.
regulation
FDA lets ZYN claim it’s safer than cigarettes — doctors push backThe FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products on 30 June 2026 — the first time any nicotine pouch has been cleared to advertise reduced disease risk versus cigarettes. The authorised claim covers mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Public health experts say the labelling could normalise nicotine for new users — and point to 460,000 youth pouch users as evidence the category is already reaching kids.
regulation
Court clips FDA’s tobacco authority — nicotine pouch rules could be nextA federal appeals court ruled the FDA exceeded its authority by requiring 11 graphic cigarette warnings — Congress only authorized nine. The same legal theory — that the agency went beyond what Congress allowed — is being used to challenge the FDA’s nicotine pouch enforcement guidance in a separate lawsuit.
regulation
Trump's FDA pick will decide the fate of unauthorized nicotine pouchesTrump has tapped White House health aide Dr. Heidi Overton to run the FDA. She'd inherit a controversial policy that lets some unauthorized nicotine pouches stay on sale while their applications sit pending — and she hasn't said whether she'd keep it.
regulation
Health groups sue the FDA as agency greenlights 30 nicotine pouch productsThe FDA has authorized 30 nicotine pouch products in 2026 — including 20 ZYN pouches with reduced-risk claims and four new flavored on! pouches. Public health groups, pediatricians and parents responded by suing the agency, arguing its enforcement policy lets products reach the market without legally required scientific review. The American Heart Association says the program was "never adequately explained to the public."
product
A child-safe cap that retrofits any nicotine pouch canChemular's Safeguard Mark I adds child-resistant packaging to existing nicotine pouch cans without a redesign — responding to FDA pressure after poison-control data showed 72% of pouch exposures involved children under 5. All 20 FDA-authorized pouch products already use CRC packaging.
science
FDA Drops PATH Wave 8 Data — Nicotine Pouch-usage in focus!The FDA just released Wave 8 of the PATH Study, the federal government's most comprehensive look at nicotine pouch usage in America. Here's what the data covers.
regulation
FDA Authorizes Four NEW Nicotine Pouches — First Signal the Category Can Market as Lower-RiskThe FDA just authorized four new on! nicotine pouch products, explicitly citing lower levels of harmful constituents compared to traditional oral tobacco. It's the first authorization of its kind — and it opens the door for pouches to claim harm reduction.
regulation
ZYN's FDA reduced-risk claim, explained: which 20 pouches have it and what it actually saysIn June 2026 the FDA let 20 ZYN nicotine pouch products carry a modified-risk claim — a first for the category. Here's the exact wording, the full product list, and why it matters for every pouch brand.